These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 17373847
1. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues. Fan E, Shi W, Lowary TL. J Org Chem; 2007 Apr 13; 72(8):2917-28. PubMed ID: 17373847 [Abstract] [Full Text] [Related]
3. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells. Wasowska M, Wietrzyk J, Opolski A, Oszczapowicz J, Oszczapowicz I. Anticancer Res; 2006 Apr 13; 26(3A):2009-12. PubMed ID: 16827137 [Abstract] [Full Text] [Related]
4. Syntheses and biological activities of 3'-azido disaccharide analogues of daunorubicin against drug-resistant leukemia. Zhang G, Fang L, Zhu L, Zhong Y, Wang PG, Sun D. J Med Chem; 2006 Mar 09; 49(5):1792-9. PubMed ID: 16509594 [Abstract] [Full Text] [Related]
5. Structure-based design of a new bisintercalating anthracycline antibiotic. Chaires JB, Leng F, Przewloka T, Fokt I, Ling YH, Perez-Soler R, Priebe W. J Med Chem; 1997 Jan 31; 40(3):261-6. PubMed ID: 9022792 [Abstract] [Full Text] [Related]
11. Oxazolinodoxorubicin - a promising new anthracycline. Lukawska M, Klopotowska D, Milczarek M, Wietrzyk J, Studzian K, Szmigiero L, Porebska A, Oszczapowicz I. Anticancer Res; 2012 Jul 31; 32(7):2959-65. PubMed ID: 22753760 [Abstract] [Full Text] [Related]
12. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation. Animati F, Arcamone F, Bigioni M, Capranico G, Caserini C, De Cesare M, Lombardi P, Pratesi G, Salvatore C, Supino R, Zunino F. Mol Pharmacol; 1996 Sep 31; 50(3):603-9. PubMed ID: 8794900 [Abstract] [Full Text] [Related]
13. Effects of structural modifications of daunorubicin on in vitro antileukemic activity. Stojak M, Mazur L, Opydo-Chanek M, Lukawska M, Oszczapowicz I. Anticancer Res; 2012 Dec 31; 32(12):5271-7. PubMed ID: 23225426 [Abstract] [Full Text] [Related]
14. [Enantioselective synthesis of anthracyclines]. Monneret C. Ann Pharm Fr; 1997 Dec 31; 55(1):5-11. PubMed ID: 9138316 [Abstract] [Full Text] [Related]
15. [Synthesis and antitumor activity of new analogs of anthracycline antibiotics modified by aglycon]. Olsuf'eva EN. Bioorg Khim; 1990 Nov 31; 16(11):1445-64. PubMed ID: 2096823 [Abstract] [Full Text] [Related]
16. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect. Schlage P, Mezo G, Orbán E, Bosze S, Manea M. J Control Release; 2011 Dec 10; 156(2):170-8. PubMed ID: 21864594 [Abstract] [Full Text] [Related]
18. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells. Taatjes DJ, Fenick DJ, Koch TH. J Med Chem; 1998 Apr 09; 41(8):1306-14. PubMed ID: 9548820 [Abstract] [Full Text] [Related]
19. A short and efficient transformation of rhamnose into activated daunosamine, acosamine, ristosamine and epi-daunosamine derivatives, and synthesis of an anthracycline antibiotic acosaminyl-epsilon-iso-rhodomycinone. Renneberg B, Li YM, Laatsch H, Fiebig HH. Carbohydr Res; 2000 Dec 01; 329(4):861-72. PubMed ID: 11125829 [Abstract] [Full Text] [Related]
20. Syntheses and biological activities of disaccharide daunorubicins. Zhang G, Fang L, Zhu L, Aimiuwu JE, Shen J, Cheng H, Muller MT, Lee GE, Sun D, Wang PG. J Med Chem; 2005 Aug 11; 48(16):5269-78. PubMed ID: 16078845 [Abstract] [Full Text] [Related] Page: [Next] [New Search]